Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136


Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats.

Sun T, He W, Hu G, Li M.

Pharmacol Biochem Behav. 2010 May;95(3):298-307. doi: 10.1016/j.pbb.2010.02.005. Epub 2010 Feb 16.


Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.

Qiao J, Zhang Q, Li M.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:177-85. doi: 10.1016/j.pnpbp.2013.10.005. Epub 2013 Oct 16.


Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

Zhang C, Fang Y, Li M.

Pharmacol Biochem Behav. 2011 Mar;98(1):155-60. doi: 10.1016/j.pbb.2010.12.018. Epub 2010 Dec 29.


Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.

Yokoyama F, Yamauchi M, Oyama M, Okuma K, Onozawa K, Nagayama T, Shinei R, Ishikawa M, Sato Y, Kakui N.

Psychopharmacology (Berl). 2009 Aug;205(2):177-87. doi: 10.1007/s00213-009-1528-1. Epub 2009 Apr 9.


The contribution of contextual fear in the anxiolytic effect of chlordiazepoxide in the fear-potentiated startle test.

Zhao Y, Bijlsma EY, Verdouw PM, Garssen J, Groenink L.

Behav Brain Res. 2018 Nov 1;353:57-61. doi: 10.1016/j.bbr.2018.06.035. Epub 2018 Jun 30.


Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?

Qiao J, Gao J, Shu Q, Zhang Q, Hu G, Li M.

Psychopharmacology (Berl). 2014 Apr;231(8):1649-1659. doi: 10.1007/s00213-013-3386-0. Epub 2013 Dec 21.


An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigm.

Li M, He W, Mead A.

Behav Pharmacol. 2009 Mar;20(2):184-94. doi: 10.1097/FBP.0b013e32832a8f66.


Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.

Heldt SA, Davis M, Ratti E, Corsi M, Trist D, Ressler KJ.

Behav Pharmacol. 2009 Oct;20(7):584-95. doi: 10.1097/FBP.0b013e32832ec594.


Time course of the antipsychotic effect and the underlying behavioral mechanisms.

Li M, Fletcher PJ, Kapur S.

Neuropsychopharmacology. 2007 Feb;32(2):263-72. Epub 2006 May 31.


No effect of sex and estrous cycle on the fear potentiated startle response in rats.

Zhao Y, Bijlsma EY, Verdouw MP, Groenink L.

Behav Brain Res. 2018 Oct 1;351:24-33. doi: 10.1016/j.bbr.2018.05.022. Epub 2018 May 24.


Olanzapine counteracts stress-induced anxiety-like behavior in rats.

Locchi F, Dall'olio R, Gandolfi O, Rimondini R.

Neurosci Lett. 2008 Jun 20;438(2):146-9. doi: 10.1016/j.neulet.2008.04.017. Epub 2008 Apr 10.


Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice.

Smith KS, Engin E, Meloni EG, Rudolph U.

Neuropharmacology. 2012 Aug;63(2):250-8. doi: 10.1016/j.neuropharm.2012.03.001. Epub 2012 Mar 21.


The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.

Li X, Kaczanowska K, Finn MG, Markou A, Risbrough VB.

Neuropharmacology. 2015 Oct;97:357-64. doi: 10.1016/j.neuropharm.2015.05.001. Epub 2015 May 19.


The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Steiner MA, Lecourt H, Jenck F.

Psychopharmacology (Berl). 2012 Oct;223(4):465-75. Epub 2012 May 17.


Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.

Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA Jr.

J Pharmacol Exp Ther. 2007 Dec;323(3):838-45. Epub 2007 Sep 6.

Supplemental Content

Support Center